May 9 (Reuters) - Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the ...
Steve Pagliuca, Bain Capital chairperson, joins 'Money Movers' to discuss private equity's entrance into the NFL, private equity's conflicting interests, and much more. Got a confidential news tip? We ...
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Bain Capital Co-Managing Partner David Gross speaks to CNBC’s Dan Murphy at Abu Dhabi Finance Week, discussing investment opportunities in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results